Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.7K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-onset neuroinflammation drives neurodegeneration caused by lysosomal PI(3,5)P<sub>2</sub> insufficiency.

Neurobiology of disease·2026
Same author

Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model.

The Journal of clinical investigation·2026
Same author

Protein family FAM241 in human and mouse.

Mammalian genome : official journal of the International Mammalian Genome Society·2024
Same author

Allele-Specific Editing of a Dominant SCN8A Epilepsy Variant Protects against Seizures and Lethality in a Murine Model.

Annals of neurology·2024
Same author

Dentate gyrus granule cells are a locus of pathology in Scn8a developmental encephalopathy.

Neurobiology of disease·2024
Same author

A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants.

HGG advances·2024

Related Experiment Video

Updated: Dec 31, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.5K

SCN8A encephalopathy: Mechanisms and models.

Miriam H Meisler1

  • 1Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.

Epilepsia
|January 7, 2020
PubMed
Summary

De novo SCN8A mutations cause epileptic encephalopathy by increasing neuronal excitability. Mouse models of these mutations aid in developing new therapies for this severe neurological disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • De novo mutations in the SCN8A gene are implicated in approximately 2% of epileptic encephalopathy cases.
  • These mutations affect the Nav1.6 sodium channel, leading to neuronal hyperexcitability and seizures.

Purpose of the Study:

  • To investigate the in vivo effects of patient-derived SCN8A mutations (N1768D and R1872W) on neuronal function.
  • To establish and utilize mouse models for preclinical drug testing in SCN8A-associated epilepsy.

Main Methods:

  • Generation of two mouse models with specific SCN8A missense mutations (N1768D and R1872W).
  • Utilized a conditional knockout strategy for the R1872W mutation to study its effects across different neuronal types and developmental stages.
  • Performed in vivo characterization of neuronal function and preclinical drug testing.
Keywords:
SCN8Aencephalopathymouse modelmutationsodium channel

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

11.1K

Related Experiment Videos

Last Updated: Dec 31, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.5K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

11.1K

Main Results:

  • The generated mouse models recapitulate key aspects of SCN8A-related epileptic encephalopathy.
  • Demonstrated that SCN8A mutations alter biophysical properties of Nav1.6, causing neuronal hyperexcitability.
  • Preclinical testing in these models supports the efficacy of potential new therapeutic strategies.

Conclusions:

  • SCN8A mutations are a significant cause of early-onset epileptic encephalopathy.
  • Mouse models are crucial for understanding the pathophysiology and developing treatments for SCN8A channelopathies.
  • Loss-of-function SCN8A mutations are linked to intellectual disability, highlighting the diverse roles of this gene.